A historical perspective of pharmaceutical promotion and physician education

JAMA

Volumn 300, Issue 7, 2008, Pages 831-833

  Podolsky, Scott H ^a   Greene, Jeremy A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PRACTICE; CONTINUING EDUCATION; DRUG INDUSTRY; MARKETING; MEDICAL EDUCATION; MEDICAL PROFESSION; MEDICAL SOCIETY; NOTE; PHYSICIAN; PRIORITY JOURNAL; ARTICLE; ECONOMICS; ETHICS; FINANCIAL MANAGEMENT; HISTORY; INTERDISCIPLINARY COMMUNICATION; LEGAL ASPECT; UNITED STATES;

DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; FINANCIAL SUPPORT; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; INTERDISCIPLINARY COMMUNICATION; MARKETING; UNITED STATES;

EID: 49949114498     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.300.7.831     Document Type: Note

References (15)

1. Steinbrook R. Financial support of continuing medical education. JAMA. 2008;299(9):1060-1062.
2. De Haen P. New products parade. Drug Cosmet Ind. 1962;90:141-142, 222, 228, 230, 234-235, 240.
3. Goodman L, Gilman A. Preface. In: The Pharmacological Basis of Therapeutics. 2nd ed. New York, NY: MacMillan; 1960.
4. Dichter E; Institute for Motivational Research. The M.D.'s prescription motivations - his four major conflicts about your drugs and ads. In: Research Study on Pharmaceutical Advertising. Croton-on-Hudson, NY: Pharmaceutical Advertising Club; 1955:39.
5. Dowling HF. Twixt the cup and the lip. JAMA. 1957;165(6):657-661.
6. Sackler A. Freedom of inquiry, freedom of thought, freedom of expression: "a standard to which the wise and the just can repair": observations on medicine, medicines, and the pharmaceutical industry; Box 5: "William Douglas McAdams," Felix Marti-Ibañez papers (October 18, 1957). Located at: Manuscripts and Archives, Yale University Library, New Haven, CT.
7. Dowling HF. Medicines for Man: The Development, Regulation, and Use of Prescription Drugs. New York, NY: Alfred A Knopf; 1970.
8. Adminstered Prices: Hearings Before the US Senate Committee on the Judiciary, Subcommittee on Antitrust and Monopoly, 86th Cong, Part 19 (1960): 10621.
9. May CD. Selling drugs by "educating" physicians. J Med Educ. 1961;36(1):1-23.
10. Continuing medical education: a professional responsibility. JAMA. 1963;185(6):533-534.
11. Ferrer JM. How are the costs of continuing medical education to be defrayed? Bull N Y Acad Med. 1975;51(6):785-788.
12. Todd JS, Johnson KH; American Medical Association Council on Ethical and Judicial Affairs. Annotated guidelines on gifts to physicians from industry. J Okla State Med Assoc. 1992;85(5):227-231.
13. Relman AS; ACCME. Defending professional independence: ACCME's proposed new guidelines for commercial support of CME. JAMA. 2003;289(18):2418- 2420.
14. Gagnon MA, Lexchin J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 2008;5(1):e1.
15. Garai PR. Advertising and promotion of drugs. In: Talalay O, ed. Drugs in Our Society. Baltimore, MD: Johns Hopkins Press; 1964:189-202.